Between innovation and biomaterials, Biologics 4 Life develops technologies that meet major public health challenges
Created in 2018 in Pertuis by Aurélien VALET, Biologics 4 Life was born out of an audacious bone reconstruction project. Specialized in biomaterials, the start-up's ambition is to develop bone substitutes capable of destroying bone cancer patients' metastases and reconstructing their bones using biotechnologies. The innovation would make it possible to treat pathologies including osteoporosis and thus meet major public health challenges.
The territorial anchoring, the potential and the work accomplished by the start-up enabled it to be awarded the French Tech Seed Provence Corse consortium. Biologics 4 Life is supported by the Impulse incubator. An investment fund dedicated to young innovative start-ups has been granted to them. It finances projects with a view to "investing in the future" to the tune of €250 K by Bpifrance. It will finance the development and structuring of the start-up and will help prepare the marketing of a first Biologics 4 Life product between now and 2021.
Biologics 4 Life works in close collaboration with clinicians and practitioners from AP-HM, AP-HP and national research organizations - CNRS and Inserm. The interest of the project is to develop and propose an easy-to-use innovation for healthcare professionals. In addition, the expertise of its founders in the marketing of biomaterials allows the start-up to benefit from a real know-how in the international marketing of innovative technologies.